数据集
![]() |
1200万项纪录 全部 |
病人基本资料病人基本资料,包括性别和出生年份。 |
![]() |
4400万项纪录 2000年起 |
急症室到诊急症室病人到诊纪录,包括到诊日期(提供至月份)、入院时的年龄、分流类别及出院资讯。 |
![]() |
8400万项纪录 1997年起 |
住院、转院及出院住院纪录,包括入院及出院日期(提供至月份)、入院时的年龄、入院来源、入院专科及出院资讯。 |
![]() |
5.23亿项纪录 2000年起 |
门诊预约门诊预约及到诊纪录,包括预约日期(提供至月份)、到诊当日的年龄、到诊专科及预约类型(首次到诊或覆诊)。 |
![]() |
1.02亿项纪录 全部 |
诊断诊断纪录,包括病人的诊断结果、诊断状态以及诊断日期(提供至月份)。 |
![]() |
3900万项纪录 全部 |
医疗程序医疗程序纪录,包括医疗程序名称及日期(提供至月份)。 |
![]() |
11.7亿项纪录 2000年起 |
药物纪录配发处方纪录,包括配发药物及其相对应英国药物处方集(BNF) 编码、处方期限及处方剂量。 |
![]() |
600万项纪录 2009年10月1日起 |
疫苗接种医院管理局的疫苗接种纪录,包括注射日期(提供至月份)及所接种的疫苗。 |
![]() |
4.38亿项记录 全部 |
家庭医学病人疾病纪录,包括疾病日期(提供至月份)及ICPC2代码。 |
![]() |
74.3万项记录 2002年起 |
产科产科纪录,包括婴儿出生日期(提供至年份)、出生时体重、产次及妊娠周数。 |
![]() |
25.38亿项纪录 2000年起 |
化验纪录化验结果纪录,包括化学病理学、血液学及免疫学、微生物学及病毒学检测,并附化验结果日期(提供至月份)。 |
![]() |
1.31亿项记录 自1999年4月1日起 |
放射检查放射检查结果,包括放射检查登记日期(提供至月份) 、放射检查内容、病人进行放射检查预约当日的年龄。 |
![]() |
1.3亿项记录 自1994年2月3日起 |
临床纪录/ 摘要临床及出院纪录,包括纪录创建日期(提供至月份)及临床纪录的文字内容。 |
![]() |
2300万项记录 自1999年4月1日起 |
放射报告放射检查报告的文字内容。 |
![]() |
(按项目而定) |
放射影像按研究需要提供的放射影像(DICOM格式)。 |
Data Products
Structured data of 14 chronic diseases:
![]() |
328K Patients 1993-2023 |
Chronic Heart Failure (CHF)A progressive condition where the heart’s ability to pump blood efficiently is impaired, leading to inadequate circulation. Symptoms include shortness of breath, fatigue, exercise intolerance, and edema (swelling in the feet, ankles, or abdomen). Common causes include coronary artery disease, history of myocardial infarction, or hypertension. Predominantly affects individuals aged 65+. |
![]() |
739K Patients 1998-2023 |
Chronic Kidney Disease (CKD) Stage 3A, 3B, 4 & 5Defined by glomerular filtration rate (GFR) <60 mL/min/1.73m² or structural/functional kidney abnormalities persisting ≥3 months. Diagnostic markers include albuminuria, urinary sediment irregularities, or tubular electrolyte disorders. Stage 3A: GFR 45–59 mL/min/1.63m² Stage 3B: GFR 30–44 mL/min/1.73m² Stage 4: GFR 15–29 mL/min/1.73m² Stage 5 (Kidney Failure): GFR <15 mL/min/1.73m² |
![]() |
186K Patients 1992-2023 |
Chronic Obstructive Pulmonary Disease (COPD)A preventable, progressive respiratory disorder characterized by persistent airflow limitation due to chronic inflammation of airways and lung tissue, typically triggered by exposure to harmful particles/gases (e.g., smoking). Exacerbations and comorbidities (e.g., cardiovascular disease) worsen disease severity. |
![]() |
561K Patients 1993-2023 |
Coronary Heart Disease (CHD)Caused by atherosclerotic narrowing/blockage of coronary arteries, reducing blood flow to the heart. Symptoms include angina, dyspnea on exertion, and myocardial infarction. Risk factors: age, smoking, hypertension, hyperlipidemia, diabetes, obesity, and family history of early-onset CHD. Also termed coronary artery disease (CAD). |
![]() |
277K Patients 1993-2023 |
DementiaA syndrome marked by progressive cognitive decline, including memory loss, impaired reasoning, personality changes, and difficulty performing daily tasks. Common etiologies include Alzheimer’s disease, cerebrovascular injury, or neurodegenerative disorders. Symptoms worsen over time. |
![]() |
856K Patients 2007-2023 |
Diabetes Mellitus (DM)A metabolic disorder characterized by chronic hyperglycemia due to defects in insulin secretion, insulin action, or both. Disrupts carbohydrate, lipid, and protein metabolism. Subtypes include Type 1 (autoimmune) and Type 2 (insulin resistance). |
![]() |
255K Patients 1993-2023 |
GlaucomaA group of eye disorders involving increased intraocular pressure, damaging the optic nerve and leading to vision loss. Caused by impaired drainage of aqueous humor, which compresses the retina and optic nerve. |
![]() |
310K Patients 1995-2023 |
Hepatitis B CarriersIndividuals with persistent hepatitis B virus (HBV) infection, defined as HBsAg-positive or HBV DNA-positive for >6 months. Carriers face elevated risks of cirrhosis and hepatocellular carcinoma (HCC), independent of liver function status. |
![]() |
162K Patients 1992-2023 |
Hip Fracture (as approximate for Osteoporosis)A fracture in the proximal femur (upper thigh bone), often caused by trauma or osteoporosis. Common in older adults and associated with reduced mobility. |
![]() |
1293K Patients 1993-2023 |
Hyperlipidemia (HLD)A group of metabolic disorders marked by elevated blood lipoprotein levels, including high cholesterol (LDL) and/or triglycerides. Major risk factor for atherosclerosis and cardiovascular disease. |
![]() |
2109K Patients 2007-2023 |
Hypertension (HT)Primary hypertension (95% of cases) refers to persistently elevated blood pressure without identifiable cause. Risk factors include age, obesity, salt sensitivity, and genetic predisposition. |
![]() |
76K Patients 1993-2023 |
ParkinsonismA clinical syndrome defined by bradykinesia plus ≥1 of the following: resting tremor, rigidity, or postural instability. Causes include Parkinson’s disease, drug-induced dopamine blockade, vascular lesions, or neurodegenerative disorders. |
![]() |
220K Patients 2001-2023 |
StrokeSudden cerebral ischemia (loss of blood flow to the brain) due to thrombosis, embolism, or hemorrhage. Symptoms include hemiparesis, aphasia, and altered consciousness. Risk factors: hypertension, atrial fibrillation, diabetes, smoking, and age. Also termed cerebrovascular accident (CVA). |
![]() |
207K Patients 1993-2023 |
DepressionA mood disorder characterized by persistent sadness, anhedonia, fatigue, sleep disturbances, and suicidal ideation. Affects 15–25% of cancer patients. Treatable with therapy and/or pharmacotherapy. |
Structured data of 11 cancers (Prevalence provided by Hong Kong Cancer Registry):
![]() |
84K Patients 2006-2023 |
Colorectal CancerMalignancy arising in the colon or rectum, often from adenomatous polyps. |
![]() |
67K Patients 2006-2023 |
Breast (Female) CancerMost commonly ductal or lobular carcinoma, originating in milk ducts or glands. Invasive forms spread beyond the primary site. |
![]() |
88K Patients 2006-2023 |
Lung CancerClassified as small cell (aggressive, linked to smoking) or non-small cell (e.g., adenocarcinoma, squamous cell). |
![]() |
33K Patients 2006-2023 |
Prostate CancerAdenocarcinoma of the prostate gland, primarily affecting older males. |
![]() |
33K Patients 2006-2023 |
Liver CancerPrimary (hepatocellular carcinoma) or secondary (metastatic spread from other organs). |
![]() |
14K Patients 2006-2023 |
Nasopharynx CancerMalignancy in the nasopharyngeal epithelium, linked to Epstein-Barr virus in endemic regions. |
![]() |
20K Patients 2006-2023 |
Stomach CancerAdenocarcinoma of the gastric mucosa. Also termed gastric cancer. |
![]() |
15K Patients 2006-2023 |
Corpus CancerMalignant tumors of the uterine corpus (e.g., endometrial carcinoma, leiomyosarcoma). |
![]() |
9K Patients 2006-2023 |
Ovary CancerIncludes epithelial carcinomas (most common) and germ cell tumors. Often diagnosed at advanced stages. |
![]() |
8K Patients 2006-2023 |
Cervix CancerMalignancy of the cervix, frequently associated with HPV infection. |
![]() |
14K Patients 2006-2023 |
Non-Hodgkin LymphomaDiverse group of lymphocyte cancers (B-cell or T-cell origin), distinct from Hodgkin lymphoma. |